Document Detail

Ability of Lactobacillus rhamnosus GAF01 to remove AFM(1) in vitro and to counteract AFM(1) immunotoxicity in vivo.
MedLine Citation:
PMID:  23030351     Owner:  NLM     Status:  Publisher    
Aflatoxin M(1) (AFM(1)) has been detected in many parts of the world both in raw milk and many dairy products, causing great economic losses and human disease. Unfortunately, there are few studies dealing with AFM(1) immunotoxicity/interactions with lactic acid bacteria for potential application as a natural preventive agent. The aim of this study was to isolate (from dairy products) food-grade probiotic bacteria able to degrade/bind AFM(1) in vitro and evaluate whether the same organism(s) could impart a protective role against AFM(1)-induced immunotoxicity in exposed Balb/c mice. Bacteria (Lactobacillus plantarum MON03 and L. rhamnosus GAF01) were isolated from Tunisian artisanal butter and then tested for abilities to eliminate AFM(1) from phosphate-buffered saline (PBS) and reconstituted milk (containing 0.05, 0.10, and 0.20 µg AFM(1)/ml) after 0, 6, and 24 h at 37°C. Results showed that the selected bacteria could 'remove' AFM(1) both in PBS and skimmed milk. The binding abilities of AFM(1) by L. plantarum MON03 and L. rhamnosus GAF01 strains (at 10(8) CFU/ml) in PBS and reconstituted milk ranged, respectively, from 16.1-78.6% and 15.3-95.1%; overall, L. rhamnosus showed a better potential for removal than L. plantarum. 'Removal' appeared to be by simple binding; the bacteria/AFM(1) complex was stable and only a very small proportion of mycotoxin was released back into the solution. L. rhamnosus GAF01 had the highest binding capacity and was selected for use in the in vivo study. Those results indicated that use of the organism prevented AFM(1)-induced effects on total white and red blood cells, and lymphocyte subtypes, after 15 days of host treatment. These studies clearly indicated that L. rhamnosus GAF01 was able to bind AFM(1) in vitro and-by mechanisms that might also be related to a binding effect-counteract AFM(1)-induced immunotoxicity. Moreover, by itself, this bacterium was not toxic and could potentially be used as an additive in dairy products and in biotechnology for mycotoxin detoxification.
Samir Abbès; Jalila Ben Salah-Abbès; Hakimeh Sharafi; Rania Jebali; Kambiz Akbari Noghabi; Ridha Oueslati
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-3
Journal Detail:
Title:  Journal of immunotoxicology     Volume:  -     ISSN:  1547-6901     ISO Abbreviation:  J Immunotoxicol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101201960     Medline TA:  J Immunotoxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Unit of Immunology, Environmental Microbiology and Cancerology, Faculty of Sciences, University of Carthage , Tunis , Tunisia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Concentration Dependence on the Shape and Size of Sol-Gel Derived Yttria-Stabilized Zirconia Ceramic...
Next Document:  Substance abuse and movement disorders: complex interactions and comorbidities.